Immix Biopharma (IMMX) EBIT (2021 - 2026)
Immix Biopharma (IMMX) recorded EBIT of -$12.46 million in Q2 2026, compared with -$6.72 million a year earlier.
Powered by 
Analysis
Immix Biopharma (IMMX) EBIT (2021 - 2026) Analysis & Trends
On a TTM basis, Immix Biopharma's EBIT came in at -$41.82 million as of Jun 30, 2026; for FY2025, it came in at -$29.96 million.
- Across earlier years, EBIT came in at -$22.67 million in FY2024, -$16.14 million in FY2023, -$8.22 million in FY2022 and -$1.35 million in FY2021.
- The Q2 2026 figure is the lowest quarterly EBIT in data going back to Q1 2021.
- Per Business Quant, the preceding three quarters came in at -$10.8 million (Q1 2026), -$10.89 million (Q4 2025) and -$7.66 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBIT (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,169.76 Bn | 1,138.35 Bn | 19.71 Bn | 11.75 Bn |
| 2 | Johnson & Johnson | 648.06 Bn | 567.92 Bn | 17.30 Bn | 6.18 Bn |
| 3 | AbbVie | 503.37 Bn | 476.48 Bn | 12.70 Bn | 6.43 Bn |
| 4 | Merck | 365.39 Bn | 319.77 Bn | 12.21 Bn | -584.00 Mn |
| 5 | Novartis Ag | 303.45 Bn | 267.44 Bn | 11.24 Bn | 4.75 Bn |
| 6 | Astrazeneca | 269.03 Bn | 242.72 Bn | 12.86 Bn | 3.16 Bn |
| 7 | Amgen | 242.08 Bn | 197.48 Bn | 7.24 Bn | 3.51 Bn |
| 8 | Gilead Sciences | 194.88 Bn | 169.07 Bn | 6.22 Bn | -10.39 Bn |
| 9 | Pfizer | 172.39 Bn | 119.04 Bn | 10.94 Bn | 4.27 Bn |
| 10 | Immix Biopharma | 530.26 Mn | 298.16 Mn | - | -12.46 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -12.46 Mn |
| Mar 31, 2026 | -10.80 Mn |
| Dec 31, 2025 | -10.89 Mn |
| Sep 30, 2025 | -7.66 Mn |
| Jun 30, 2025 | -6.72 Mn |
| Mar 31, 2025 | -4.68 Mn |
| Dec 31, 2024 | -4.99 Mn |
| Sep 30, 2024 | -7.39 Mn |
| Jun 30, 2024 | -4.70 Mn |
| Mar 31, 2024 | -5.59 Mn |
| Dec 31, 2023 | -5.38 Mn |
| Sep 30, 2023 | -4.52 Mn |
| Jun 30, 2023 | -3.72 Mn |
| Mar 31, 2023 | -2.52 Mn |
| Dec 31, 2022 | -3.79 Mn |
| Sep 30, 2022 | -1.53 Mn |
| Jun 30, 2022 | -1.56 Mn |
| Mar 31, 2022 | -1.33 Mn |
| Dec 31, 2021 | -598,338.00 |
| Sep 30, 2021 | -347,991.00 |
API Access
Immix Biopharma EBIT API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebit&ticker=IMMX&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebit", "ticker": "IMMX", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebit&ticker=IMMX&period=max&api_key=YOUR_API_KEY");
const data = await res.json();